Hyperion DeFi, Inc.
$3.78+10.04%(+$0.34)
TickerSpark Score
65/100
53
Valuation
40
Profitability
100
Growth
80
Health
50
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HYPD research report →
52-Week Range15% of range
Low $1.36
Current $3.78
High $17.18
Companyhyperiondefi.com
A U. S. -based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.
- CEO
- Hyunsu Jung
- IPO
- 2025
- Employees
- 13
- HQ
- New York, NY, US
Price Chart
-52.09% · this period
Valuation
- Market Cap
- $18.86M
- P/E
- -1.22
- P/S
- 18.09
- P/B
- 0.69
- EV/EBITDA
- -1.83
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 63.68%
- Op Margin
- -2012.57%
- Net Margin
- -3163.01%
- ROE
- -63.54%
- ROIC
- -31.07%
Growth & Income
- Revenue
- $813.46K · 1318.75%
- Net Income
- $-45,314,435 · 9.04%
- EPS
- $-9.40 · 84.28%
- Op Income
- $-18,981,294
- FCF YoY
- 51.23%
Performance & Tape
- 52W High
- $17.18
- 52W Low
- $1.36
- 50D MA
- $3.67
- 200D MA
- $5.20
- Beta
- 2.57
- Avg Volume
- 417.54K
Get TickerSpark's AI analysis on HYPD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 30, 26 | Knox David R. | other | 20,831 |
| Jan 12, 26 | Rubenstein Robert | other | 75,000 |
| Jan 12, 26 | Rubenstein Robert | other | 0 |
| Dec 31, 25 | Knox David R. | buy | 27,950 |
| Dec 29, 25 | Strahlman Ellen R | buy | 12,112 |
| Dec 26, 25 | Strahlman Ellen R | buy | 3,601 |
| Dec 29, 25 | Strahlman Ellen R | buy | 11,856 |
| Dec 26, 25 | Strahlman Ellen R | buy | 3,311 |
| Dec 29, 25 | Jung Hyunsu | other | 82,324 |
| Dec 18, 25 | Strahlman Ellen R | buy | 19,702 |
Our HYPD Coverage
We haven't published any research on HYPD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HYPD Report →Similar Companies
MODD+15.32%
Modular Medical, Inc.
$3.84
MYO+4.17%
Myomo, Inc.
$0.91
RBOT+4.76%
Vicarious Surgical Inc.
$0.88
JSPR+6.61%
Jasper Therapeutics, Inc.
$0.87
VRCA+7.69%
Verrica Pharmaceuticals Inc.
$6.02
MURA+0.00%
Mural Oncology plc
$2.04
PIII-7.63%
P3 Health Partners Inc.
$9.69
NMTC-0.49%
NeuroOne Medical Technologies Corporation
$4.09